GemPharmatech Co (SHSE:688046) FCF Margin %: -9.45% (As of Mar. 2026)

What is GemPharmatech Co FCF Margin %?

GemPharmatech Co SHSE:688046 +5.61% 95 FCF Margin % is -9.45% as of Mar. 2026. GuruFocus rates SHSE:688046 with a GF Score™ of 95/100 and a GF Value™ of ¥19.37 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 957 Biotechnology companies, GemPharmatech Co ranks better than 89.03% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GemPharmatech Co's Free Cash Flow for the three months ended in Mar. 2026 was ¥-19.7 Mil. GemPharmatech Co's Revenue for the three months ended in Mar. 2026 was ¥208.1 Mil. Therefore, GemPharmatech Co's FCF Margin % for the quarter that ended in Mar. 2026 was -9.45%.

As of today, GemPharmatech Co's current FCF Yield % is 1.63%.

The historical rank and industry rank for GemPharmatech Co's FCF Margin % or its related term are showing as below:

SHSE:688046' s FCF Margin % Range Over the Past 10 Years
Min: -16.33 Med: 1.38 Max: 76.75
Current: 19.43

During the past 8 years, the highest FCF Margin % of GemPharmatech Co was 76.75%. The lowest was -16.33%. And the median was 1.38%.

SHSE:688046's FCF Margin % is ranked better than
89.03% of 957 companies
in the Biotechnology industry
Industry Median: -84.65 vs SHSE:688046: 19.43

GemPharmatech Co FCF Margin % Related Terms

GemPharmatech Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for GemPharmatech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GemPharmatech Co FCF Margin % Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

6.16

-16.33

-14.36

-3.40

15.38

GemPharmatech Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-34.54	1.40	23.69	59.97	-9.45

SHSE:688046 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, GemPharmatech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemPharmatech Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's FCF Margin % falls into.

Save Embed

95GF Score

GemPharmatech Co Ltd SHSE:688046

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

GemPharmatech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GemPharmatech Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	122.037	/	793.389
	=	15.38 %

GemPharmatech Co's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-19.67	/	208.077
	=	-9.45 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -9.45% mean?

GemPharmatech Co (SHSE:688046) has a FCF Margin % of -9.45% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GemPharmatech Co and its competitors. According to the industry distribution chart, GemPharmatech Co ranks #105 out of 957 companies in the Biotechnology industry, placing it in the top 11%.

Is GemPharmatech Co's FCF Margin % too high?

GemPharmatech Co's current FCF Margin % is -9.45%. Based on the distribution chart, GemPharmatech Co ranks #105 out of 957 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GemPharmatech Co has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does GemPharmatech Co's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, GemPharmatech Co ranks #105 out of 957 companies for FCF Margin %. This places GemPharmatech Co in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GemPharmatech Co and its competitors. GemPharmatech Co's current FCF Margin % is -9.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is GemPharmatech Co stock overvalued right now?

Based on GuruFocus' analysis, GemPharmatech Co (SHSE:688046) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥19.37, compared to a current price of ¥24.08 — trading 24.3% above its estimated fair value. The current FCF Margin % is -9.45%. GemPharmatech Co's overall GF Score™ is 95/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For GemPharmatech Co (SHSE:688046), the current FCF Margin % is -9.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GemPharmatech Co (SHSE:688046) Overvalued in 2026?

Based on GuruFocus' analysis, GemPharmatech Co stock appears to be overvalued. The current stock price of ¥24.08 is trading 24.3% above its estimated GF Value™ of ¥19.37. GuruFocus considers GemPharmatech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688046:

FCF Margin %: -9.45%
GF Value™: ¥19.37 vs. price of ¥24.08 (24.3% above fair value)
GF Score™: 95/100 with 8 warning signs

No single metric tells the full story. See the SHSE:688046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GemPharmatech Co Business Description

Industry Healthcare Biotechnology

Comparable Companies SHSE:688105 SZSE:000403 SZSE:301207 SHSE:688076 SZSE:000990 SHSE:688202 SHSE:688443 SZSE:300049 SHSE:688739 SHSE:600645 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of genetically engineered mouse models and services to preclinical research and development communities. The company develops mouse models with independent intellectual property rights based on technical platforms such as gene editing, stem cells, phenotypic analysis, efficacy analysis, and sterile animals, and carries out one-stop services such as model customization, customized breeding, and functional efficacy analysis.

95GF Score

Get the complete analysis for SHSE:688046

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.08

Price

¥19.37

GF Value

View SHSE:688046 Analysis

See FCF Margin % data for all stocks →